-
Picato Recalls Continue with Canada and Denmark Being Most Recent, All Due to Risk of Skin Cancer
A Global Phase-out of Picato Sales by LEO Pharma Inc. Due to this Picato Safety Finding Expected by End of 2020 (Posted by Tom Lamb at DrugInjuryWatch.com) But first, we get…
-
Drug Safety Issue for Stelara: Severe Cardiovascular Events Soon After Initiation of Stelara Treatment
Stelara-Associated Acute Coronary Syndrome, Stroke, and Unstable Angina Seen in Recent Stelara French Medical Study (Posted by Tom Lamb at DrugInjuryWatch.com) Stelara (ustekinumab) was approved by the FDA in 2009, initially for…
-
Ocaliva FDA Adverse Events Reports for Hepatobiliary System Cases: An Analysis as of October 2020
Lack of Warnings in Current Ocaliva Drug Label for Some Serious Side Effects Involving Liver, Gallbladder, Bile Ducts (Posted by Tom Lamb at DrugInjuryWatch.com) We are still wondering how the current FDA…
-
Potential Ocaliva – Liver Disorder Safety Signal Being Investigated by FDA as Side Effects Risk
October 2020 News Report Reveals "New" Ocaliva Liver Safety Issue, Which Had Been Under the Radar Previously (Posted by Tom Lamb at DrugInjuryWatch.com) Ocaliva (obeticholic acid) was approved by the FDA in…
-
Beovu: Should Use of This Eye Drug be Suspended Until Safety Investigation is Finished?
Numerous Case Reports of Occlusive Retinal Vasculitis and Vision Loss in Patients Following Beovu Injections (Posted by Tom Lamb at DrugInjuryWatch.com) As early as May 2020 it was suggested by the authors…